Min Pa: Min Pa(max): Activity's type:

Ext	Pa	Pi	Pmax	Activity	Other Results	ID Pa_max
	0.825	0.002	0.825	Anesthetic general	0.757 0.003 DBMET01816
	0.79	0.005	0.79	Thyroid hormone antagonist	0.342 0.076 DBMET01816
	0.68	0.005	0.68	Immunosuppressant	0.461 0.044 DBMET01816
	0.669	0.004	0.669	Acetylcholinesterase inhibitor	0.135 0.065 DBMET01816
	0.641	0.004	0.641	Cholinergic
	0.568	0.004	0.568	Butyrylcholinesterase inhibitor	0.279 0.012 DBMET01816
	0.375	0.006	0.375	Aldehyde dehydrogenase inhibitor	0.176 0.035 DBMET01816
	0.327	0.033	0.327	5 Hydroxytryptamine uptake stimulant	0.327 0.033 DBMET01816
	0.315	0.029	0.315	Platelet adhesion inhibitor	0.191 0.076 DBMET01816
	0.284	0.004	0.284	Carbonic anhydrase VB inhibitor	0.146 0.009 DBMET01816
	0.339	0.068	0.339	Immunostimulant	0.332 0.07 DBMET01816
	0.276	0.007	0.276	Carbonic anhydrase XIII inhibitor	0.229 0.01 DBMET01816
	0.258	0.004	0.258	Carbonic anhydrase V inhibitor	0.154 0.014 DBMET01816
	0.37	0.124	0.37	MAP kinase 1 inhibitor
	0.171	0.007	0.171	Carbonic anhydrase VA inhibitor	0.068 0.049 DBMET01816
	0.164	0.003	0.164	Estrone sulfatase inhibitor
	0.195	0.035	0.219	Alkaline phosphatase inhibitor	0.219 0.027 DBMET01816	DBMET01816
	0.18	0.02	0.18	Carbonic anhydrase III inhibitor
	0.206	0.053	0.206	5 Hydroxytryptamine 3E antagonist	0.206 0.053 DBMET01816
	0.168	0.018	0.168	Androgen antagonist
	0.154	0.01	0.154	Purinergic P2X2 antagonist	0.131 0.017 DBMET01816
	0.147	0.006	0.147	Carbonic anhydrase VII inhibitor
	0.307	0.186	0.48	Caspase 9 stimulant	0.48 0.068 DBMET01816	DBMET01816
	0.12	0.01	0.12	Androgen agonist
	0.133	0.025	0.133	Carbonic anhydrase VI inhibitor
	0.235	0.143	0.235	Apoptosis antagonist
	0.141	0.072	0.186	Heat shock protein 70 antagonist	0.186 0.01 DBMET01816	DBMET01816
	0.064	0.015	0.064	Alpha 1b adrenoreceptor agonist	0.064 0.015 DBMET01816
	0.123	0.076	0.165	Cyclooxygenase 2 inhibitor	0.165 0.044 DBMET01816	DBMET01816
	0.075	0.028	0.075	Purinergic P2X1 antagonist	0.075 0.028 DBMET01816
	0.224	0.179	0.366	Calcium channel activator	0.366 0.04 DBMET01816	DBMET01816
	0.072	0.027	0.072	Transcription factor RelA inhibitor	0.072 0.027 DBMET01816
	0.065	0.022	0.065	Carbonic anhydrase XIV inhibitor
	0.059	0.02	0.059	Carbonic anhydrase IV inhibitor
	0.137	0.104	0.184	Arachidonic acid antagonist	0.184 0.049 DBMET01816	DBMET01816
	0.055	0.029	0.065	Lysophosphatidic acid 3 receptor antagonist	0.065 0.018 DBMET01816	DBMET01816
	0.117	0.103	0.171	Cyclooxygenase inhibitor	0.171 0.056 DBMET01816	DBMET01816
	0.182	0.171	0.182	Tyrosine 3 hydroxylase inhibitor	0.182 0.171 DBMET01816
	0.211	0.201	0.211	15-Lipoxygenase inhibitor
	0.038	0.028	0.038	Alpha 1d adrenoreceptor agonist	0.038 0.028 DBMET01816
	0.046	0.042	0.046	Carbonic anhydrase XII inhibitor
	0.019	0.015	0.019	Inosine monophosphate dehydrogenase 1 inhibitor
	0.014	0.011	0.026	Purinergic receptor agonist	0.026 0.005 DBMET01816	DBMET01816
	0.014	0.011	0.026	Purinergic P2 agonist	0.026 0.005 DBMET01816	DBMET01816
	0.106	0.104	0.106	Sphingosine 1-phosphate receptor 4 antagonist	0.106 0.104 DBMET01816
	0.015	0.013	0.015	Purinergic P2Y1 antagonist
	0.014	0.014	0.016	Purinergic P2Y1 agonist	0.016 0.01 DBMET01816	DBMET01816
	0.01	0.011	0.02	Purinergic P2Y agonist	0.02 0.005 DBMET01816	DBMET01816
	0.027	0.028	0.036	Lysophosphatidic acid 2 receptor antagonist	0.036 0.015 DBMET01816	DBMET01816
	0.149	0.154	0.252	Glyceraldehyde-3-phosphate dehydrogenase inhibitor	0.252 0.042 DBMET01816	DBMET01816
	0.008	0.014	0.01	Purinergic P2Y2 agonist	0.01 0.008 DBMET01816	DBMET01816
	0.076	0.085	0.141	Triose-phosphate isomerase inhibitor	0.141 0.023 DBMET01816	DBMET01816
	0.098	0.109	0.354	Bone formation stimulant	0.354 0.012 DBMET01816	DBMET01816
	0.017	0.031	0.039	Purinergic P2X agonist	0.039 0.013 DBMET01816	DBMET01816
	0.063	0.082	0.1	Keratolytic	0.1 0.031 DBMET01816	DBMET01816
	0.016	0.04	0.039	Fructose-1,6-bisphosphatase 1 inhibitor	0.039 0.004 DBMET01816	DBMET01816
	0.035	0.067	0.059	Cholesterol esterase inhibitor	0.059 0.018 DBMET01816	DBMET01816
	0.034	0.069	0.097	Beta tubulin antagonist	0.097 0.023 DBMET01816	DBMET01816
	0.03	0.067	0.081	Fructose-1,6-bisphosphatase inhibitor	0.081 0.007 DBMET01816	DBMET01816
	0.048	0.089	0.065	Ryanodine receptor antagonist	0.065 0.025 DBMET01816	DBMET01816
	0.022	0.065	0.085	Growth factor receptor-bound protein 2 antagonist	0.085 0.002 DBMET01816	DBMET01816
	0.047	0.092	0.134	Porphobilinogen synthase inhibitor	0.134 0.024 DBMET01816	DBMET01816
	0.016	0.067	0.028	Vanilloid 2 agonist	0.028 0.012 DBMET01816	DBMET01816
	0.079	0.13	0.145	Cyclooxygenase 1 inhibitor	0.145 0.059 DBMET01816	DBMET01816
	0.077	0.136	0.419	Tubulin antagonist	0.419 0.011 DBMET01816	DBMET01816
	0.063	0.127	0.098	Expectorant	0.098 0.071 DBMET01816	DBMET01816
	0.114	0.183	0.371	Non-steroidal antiinflammatory agent	0.371 0.017 DBMET01816	DBMET01816
	0.071	0.153	0.117	Microtubule formation inhibitor	0.117 0.064 DBMET01816	DBMET01816
	0.064	0.148	0.092	Xanthine oxidase inhibitor	0.092 0.068 DBMET01816	DBMET01816
	0.088	0.183	0.183	Mannose-6-phosphate isomerase inhibitor	0.183 0.04 DBMET01816	DBMET01816
	0.016	0.116	0.032	1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor	0.032 0.028 DBMET01816	DBMET01816
	0.069	0.172	0.105	DOPA decarboxylase inhibitor	0.105 0.066 DBMET01816	DBMET01816
	0.056	0.161	0.093	NADH dehydrogenase inhibitor	0.093 0.052 DBMET01816	DBMET01816
	0.08	0.197	0.279	Phospholipase A2 inhibitor	0.279 0.017 DBMET01816	DBMET01816
	0.055	0.179	0.139	DNA directed RNA polymerase inhibitor	0.139 0.028 DBMET01816	DBMET01816
	0.034	0.169	0.056	Corticotropin releasing factor 2 receptor antagonist	0.056 0.055 DBMET01816	DBMET01816
	0.064	0.202	0.147	Cyclooxygenase 3 inhibitor	0.147 0.051 DBMET01816	DBMET01816
	0.087	0.226	0.151	Adenylate cyclase stimulant	0.151 0.061 DBMET01816	DBMET01816
	0.064	0.207	0.146	NADPH oxidase inhibitor	0.146 0.057 DBMET01816	DBMET01816
	0.056	0.199	0.078	D-Ala-D-Ala ligase inhibitor	0.078 0.075 DBMET01816	DBMET01816
	0.061	0.213	0.098	Adenylate kinase inhibitor	0.098 0.071 DBMET01816	DBMET01816
	0.085	0.242	0.167	Hypolipemic	0.167 0.121 DBMET01816	DBMET01816
	0.045	0.207	0.091	UDP-glucose 4-epimerase inhibitor	0.091 0.072 DBMET01816	DBMET01816
	0.068	0.236	0.209	Pyruvate kinase inhibitor	0.209 0.076 DBMET01816	DBMET01816
	0.014	0.183	0.053	Leukocyte elastase inhibitor	0.053 0.022 DBMET01816	DBMET01816
	0.082	0.253	0.133	Melanin inhibitor	0.133 0.109 DBMET01816	DBMET01816
	0.029	0.207	0.065	Potassium channel intermediate-conductance Ca-activated blocker	0.065 0.032 DBMET01816	DBMET01816
	0.079	0.257	0.133	Vanilloid 1 agonist	0.133 0.061 DBMET01816	DBMET01816
	0.068	0.257	0.156	Transcription factor STAT6 inhibitor	0.156 0.019 DBMET01816	DBMET01816
	0.038	0.227	0.091	Sphingomyelinase inhibitor	0.091 0.07 DBMET01816	DBMET01816
	0.044	0.237	0.081	UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor	0.081 0.079 DBMET01816	DBMET01816
	0.024	0.229	0.084	ZAP-70 protein tyrosine kinase inhibitor	0.084 0.03 DBMET01816	DBMET01816
	0.111	0.319	0.205	RNA-directed DNA polymerase inhibitor	0.205 0.092 DBMET01816	DBMET01816
	0.012	0.223	0.036	RNA-directed RNA polymerase inhibitor	0.036 0.022 DBMET01816	DBMET01816
	0.106	0.317	0.292	Cholesterol antagonist	0.292 0.096 DBMET01816	DBMET01816
	0.014	0.24	0.046	Purinergic P2Y2 antagonist	0.046 0.012 DBMET01816	DBMET01816
	0.019	0.247	0.061	Sphingosine 1-phosphate receptor 4 agonist	0.061 0.054 DBMET01816	DBMET01816
	0.038	0.268	0.171	Breast cancer-resistant protein inhibitor	0.171 0.018 DBMET01816	DBMET01816
	0.097	0.33	0.377	Transcription factor STAT3 inhibitor	0.377 0.024 DBMET01816	DBMET01816
	0.052	0.295	0.096	TRPA1 agonist	0.096 0.095 DBMET01816	DBMET01816
	0.048	0.296	0.087	Phosphodiesterase 6D inhibitor	0.087 0.086 DBMET01816	DBMET01816
	0.024	0.311	0.097	Histone deacetylase SIRT1 stimulant	0.097 0.03 DBMET01816	DBMET01816
	0.024	0.311	0.097	Histone deacetylase stimulant	0.097 0.03 DBMET01816	DBMET01816
	0.055	0.342	0.137	Hexokinase inhibitor	0.137 0.095 DBMET01816	DBMET01816
	0.083	0.372	0.409	Transcription factor STAT inhibitor	0.409 0.017 DBMET01816	DBMET01816
	0.06	0.413	0.154	Phospholipase C inhibitor	0.154 0.098 DBMET01816	DBMET01816
	0.074	0.441	0.26	Transcription factor inhibitor	0.26 0.18 DBMET01816	DBMET01816
	0.015	0.45	0.106	Potassium channel (Ca-activated) blocker	0.106 0.008 DBMET01816	DBMET01816
	0.011	0.498	0.026	Toll-Like receptor 4 agonist	0.026 0.019 DBMET01816	DBMET01816
	0.037	0.525	0.257	DNA directed DNA polymerase inhibitor	0.257 0.187 DBMET01816	DBMET01816
	0.026	0.539	0.153	DNA polymerase I inhibitor	0.153 0.047 DBMET01816	DBMET01816
	0.006	0.556	0.17	c-Src kinase inhibitor	0.17 0.046 DBMET01816	DBMET01816
	0.023	0.589	0.107	Toll-Like receptor 4 antagonist	0.107 0.059 DBMET01816	DBMET01816
	0.013	0.67	0.452	Antimitotic	0.452 0.017 DBMET01816	DBMET01816
	0.003	0.669	0.03	Sphingosine 1-phosphate receptor 3 agonist	0.03 0.027 DBMET01816	DBMET01816
	0.008	0.686	0.14	Src kinase inhibitor	0.14 0.091 DBMET01816	DBMET01816
	0.011	0.744	0.232	Platelet aggregation inhibitor	0.232 0.061 DBMET01816	DBMET01816
	0.023	0.78	0.452	Apoptosis agonist	0.452 0.09 DBMET01816	DBMET01816
	0.012	0.823	0.222	Angiogenesis inhibitor	0.222 0.146 DBMET01816	DBMET01816
	0.022	0.918	0.146	Catenin beta inhibitor	0.146 0.116 DBMET01816	DBMET01816
	0.005	0.91	0.208	Vasodilator	0.208 0.099 DBMET01816	DBMET01816
Ext	Pa	Pi	Pmax	Activity	Other Results	ID Pa_max